Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation

Khalil Jawad; Stefan Feder; Markus Barten; Jens Garbade

doi:10.1093/ejcts/ezy051

Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation

Khalil Jawad
Stefan Feder
Markus Barten
Jens Garbade

Beteiligte Einrichtungen

Klinik und Poliklinik für Herz- und Gefäßchirurgie

Abstract

Heart transplantation is the gold standard therapy for patients diagnosed with end-stage heart failure. Despite the shortage of appropriate donor organs, the transplantation of hepatitis C-infected hearts is disputed. Previous research has shown that long-term results are controversial, and the risk of severe clinical infection should not be underestimated.

Bibliografische Daten

Originalsprache	Englisch
ISSN	1010-7940
DOIs	https://doi.org/10.1093/ejcts/ezy051
Status	Veröffentlicht - 01.08.2018

PubMed	29514173